Kure Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Kure Advisory’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-487	Closed	-$258K	–	102
2023 Q4	$258K	Sell	487 -83	-15%	-$40.2K	0.13%	88
2023 Q3	$289K	Buy	+570	New	+$304K	0.16%	73

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Kure Advisory's TMO Position: Q1 2024 in Review

Kure Advisory sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 487 shares — an estimated $258K sold.

Kure Advisory first reported a position in TMO in Q3 2023 and held it in 2 quarters. The position peaked at $289K in Q3 2023. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

Kure Advisory reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
Kure Advisory sold 487 Thermo Fisher Scientific shares in Q1 2024, an estimated $258K.
Kure Advisory first reported a position in Thermo Fisher Scientific in Q3 2023 and held it in 2 quarters.
Kure Advisory's Thermo Fisher Scientific position peaked at $289K in Q3 2023.
2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Kure Advisory's 13F filing for Q1 2024, filed 9 May 2024.